Importin α inhibitors act against the differentiated stages of apicomplexan parasitesPlasmodium falciparumandToxoplasma gondii

Author:

Bhambid ManasiORCID,Walunj SujataORCID,C. A. Anupama,Jain Shilpi,Mehta Diksha,Wagstaff KylieORCID,Panda Ashutosh,Jans David A.ORCID,Mohmmed AsifORCID,Patankar SwatiORCID

Abstract

AbstractProtozoan parasites of the phylum Apicomplexa, includingPlasmodium falciparumandToxoplasma gondii, cause widespread disease in humans. New drugs and protein targets are required for the treatment of these diseases, particularly therapies targeting multiple stages of the parasite life cycles. Nuclear import, carried out by the transporter’s importin (IMP) α and β subunits, is a valid target for the discovery of lead compounds against these protozoan parasites: small molecules were identified that inhibit interactions between IMPα and nuclear localisation signalsin vitroand also inhibit the growth of the rapidly-dividing stages ofP. falciparumandT. gondii(asexual stages and tachyzoites) in culture. In this report, we add another small molecule (Bay 11-7082) to the panel of inhibitors of IMPα and test the ability of these inhibitors to first, inhibit nuclear transport in the rapidly dividing stages and, next, the maturation of differentiated stages of both parasites. We show that GW5074 and CAPE inhibit nuclear transport in theP. falciparumblood stages, while Bay 11-7085 inhibits nuclear transport inT. gondiitachyzoites. Interestingly, CAPE strongly inhibits gametocyte maturation, the sexual stages ofP. falciparum, and Bay 11-7085 weakly inhibits bradyzoite differentiation, the latent stages ofT. gondii. As differentiation of both these stages is dependent on activation of gene expression, triggered by the nuclear translocation of transcription factors, our work provides a “proof of concept” that targeting nuclear import is a viable strategy for the development of therapeutics against multiple stages of apicomplexan parasites, some of them recalcitrant to existing drugs.

Publisher

Cold Spring Harbor Laboratory

Reference53 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3